InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Carter Laura, Chief Scientific Officer. Officer active across 1 company, notably Gossamer Bio, Inc.. Aggregated, 10 reports have been published. Split: 1 buy · 7 sells. Total volume traded: €316k. Activity tracked since 3 May 2021. The latest transaction was disclosed on 16 March 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Carter Laura
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
6,029 shares@ US$1.0981.8% of flowCommon StockSEC:0001728117-23-000016:0
4,876 shares@ US$12.07317.5% of flowCommon StockSEC:0001728117-22-000094:0
4,876 shares@ US$12.07317.5% of flowCommon StockSEC:0001728117-22-000090:0
6,934 shares@ US$7.2114.6% of flowCommon StockSEC:0001728117-22-000065:0
Canonical exit: 13 Oct 2022 (T+90)
8,808 shares@ US$8.24820.3% of flowCommon StockSEC:0001728117-22-000053:0
1,262 shares@ US$7.200.011% mcap8.9% of flowCommon StockSEC:0001728117-22-000041:0
5,002 shares@ US$8.2780.047% mcap39.1% of flowCommon StockSEC:0001728117-22-000027:0
2,377 shares@ US$12.259.8% of flowCommon StockSEC:0001728117-21-000098:0
25,000 shares0Common StockSEC:0001728117-21-000080:0
10,820 shares0Common StockSEC:0001728117-21-000050:0
10 of 10 declarations
About Carter Laura
Laura Carter is the Chief Scientific Officer at Gossamer Bio, Inc. She oversees research and development initiatives aimed at innovating in the biotechnology field. Carter is recognized for her scientific expertise and commitment to advancing medical treatments.
